MPM BioImpact LLC

-

Assets, Funds, Holdings

Home | Sign Up | Log In
Message
Happy Holidays!! thanks for using AUM13F!!
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
MPM BioImpact LLC
CIK #0001687078
CIK Period
0001687078
Sector Form 13F Holdings Value ($M)
Cullinan Oncology Inc 57.6
Synta Pharmaceuticals Corp 30.4
Zai Lab Ltd 26.1
Guardant Health Inc 23.0
Silverback Therapeutics Inc 22.7
Edgewise Therapeutics Inc 22.6
Avidity Biosciences Inc 21.6
PTC Therapeutics Inc 21.4
Trevi Therapeutics Inc 18.6
Oric Pharmaceuticals Inc 17.6
Natera Inc 16.7
Alkermes PLC 15.7
Helix Acquisition Corp 14.8
MBX Biosciences Inc 14.8
Olivia Ventures Inc 14.6
Ultragenyx Pharmaceutical Inc 14.4
Janux Therapeutics Inc 14.2
Tarsus Pharmaceuticals Inc 13.8
Dyne Therapeutics Inc 13.8
Vera Therapeutics Inc 13.3
Crinetics Pharmaceuticals Inc 12.3
Revolution Medicines Inc 11.6
Akebia Therapeutics Inc 10.5
Olema Pharmaceuticals Inc 10.1
Xenon Pharmaceuticals Inc 10.1
Wave Life Sciences Ltd 9.8
DBV Technologies Sa 9.6
Context Therapeutics Inc 9.6
Inotek Pharmaceuticals Corp 9.6
Replimune Group Inc 9.1
Prev | Page 1 | Next
EDGAR Form CIK 2011 - 2025
13F-HR [0001687078]
3 [0001687078]
4 [0001687078]
SC 13D [0001687078]
SC 13G [0001687078]
Form 13D/13G Filer Form 13D/13G Subject Filed
MPM Bioimpact LLC Compass Therapeutics Inc [2025-02-14]
MPM Bioimpact LLC Context Therapeutics Inc [2025-01-08]
Bioimpact Capital LLC Reunion Neuroscience Inc [2023-06-12]
Form 3/4/5 Subject 2011 - 2025
iTeos Therapeutics, Inc.
MPM BioImpact LLC
UBS Oncology Impact Fund L.P.
Oncology Impact Fund (Cayman) Management L.P.
Gadicke Ansbert
MPM Oncology Innovations Fund GP LLC
MPM Asset Management LLC
MPM Oncology Innovations Fund LP
Werewolf Therapeutics, Inc.
TCR2 Therapeutics Inc
View All
Terms | Privacy | Guide
tony@aum13f.com